$INSM
INSMED Inc Stock $insm

$insm Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000110450620000019 Filed on October 29, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$41.42M	$43.64M	$38.89M
YoY Change	-9.38%	12.24%
Cost Of Revenue	$10.86M	$10.62M	$6.437M
YoY Change	24.68%	65.01%
Gross Profit	$30.55M	$33.02M	$32.45M
YoY Change	-17.44%	1.77%
Gross Profit Margin	73.76%	75.66%	83.45%
Selling, General & Admin	$56.02M	$46.59M	$53.35M
YoY Change	11.57%	-12.67%	20.02%
% of Gross Profit	183.37%	141.09%	164.42%
Research & Development	$67.81M	$41.41M	$34.34M
YoY Change	107.81%	20.59%	-13.15%
% of Gross Profit	221.96%	125.41%	105.83%
Depreciation & Amortization	$3.840M	$3.640M	$2.250M
YoY Change	8.47%	61.78%	136.84%
% of Gross Profit	12.57%	11.02%	6.93%
Operating Expenses	$125.1M	$41.41M	$34.34M
YoY Change	48.77%	20.59%	-59.11%
Operating Profit	-$94.54M	-$56.22M	-$56.49M
YoY Change	100.8%	-0.47%	-32.74%
Interest Expense	-$7.470M	$7.185M	$6.846M
YoY Change	40.68%	4.95%	2.56%
% of Operating Profit
Other Income/Expense, Net	$420.0K	-$4.000K	-$85.00K
YoY Change	-250.0%	-95.29%	-138.64%
Pretax Income	-$101.6M	-$63.34M	-$60.53M
YoY Change	92.92%	4.64%	-30.97%
Income Tax	$620.0K	$300.0K	$100.0K
% Of Pretax Income
Net Earnings	-$102.2M	-$63.66M	-$60.68M
YoY Change	92.89%	4.91%	-30.84%
Net Earnings / Revenue	-246.76%	-145.86%	-156.06%
Basic Earnings Per Share		-$0.63
Diluted Earnings Per Share	-$998.8K	-$0.63	-$679.9K
COMMON SHARES
Basic Shares Outstanding	101.9M shares	101.6M shares	89.25M shares
Diluted Shares Outstanding		101.6M shares	89.25M shares

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$532.8M	$588.8M	$535.6M
YoY Change	9.31%	9.93%	-5.64%
Cash & Equivalents	$532.8M	$588.8M	$535.6M
Short-Term Investments
Other Short-Term Assets	$24.00M	$19.70M	$21.30M
YoY Change	18.81%	-7.51%	115.15%
Inventory	$49.59M	$43.48M	$23.31M
Prepaid Expenses
Receivables	$16.56M	$15.20M	$15.35M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$622.9M	$667.1M	$595.6M
YoY Change	12.19%	12.01%	3.14%
LONG-TERM ASSETS
Property, Plant & Equipment	$53.95M	$55.31M	$53.00M
YoY Change	-10.35%	4.37%	171.43%
Goodwill	$0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$26.80M	$25.20M	$19.60M
YoY Change	32.02%	28.57%	326.09%
Total Long-Term Assets	$173.3M	$173.6M	$167.5M
YoY Change	-7.4%	3.61%	99.38%
TOTAL ASSETS
Total Short-Term Assets	$622.9M	$667.1M	$595.6M
Total Long-Term Assets	$173.3M	$173.6M	$167.5M
Total Assets	$796.2M	$840.7M	$763.1M
YoY Change	7.26%	10.17%	15.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$42.85M	$22.15M	$20.42M
YoY Change	225.04%	8.48%	23.14%
Accrued Expenses	$37.81M	$35.15M	$38.91M
YoY Change	-6.36%	-9.66%	-3.62%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.100M	$600.0K
YoY Change	-8.33%
Total Short-Term Liabilities	$118.8M	$83.90M	$85.39M
YoY Change	39.38%	-1.74%	48.72%
LONG-TERM LIABILITIES
Long-Term Debt	$356.3M	$351.1M	$331.0M
YoY Change	6.07%	6.08%	6.14%
Other Long-Term Liabilities	$9.178M	$10.42M	$11.26M
YoY Change	-13.48%	-7.46%	1263.68%
Total Long-Term Liabilities	$365.5M	$361.6M	$342.3M
YoY Change	5.47%	5.63%	9.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$118.8M	$83.90M	$85.39M
Total Long-Term Liabilities	$365.5M	$361.6M	$342.3M
Total Liabilities	$520.3M	$483.7M	$459.1M
YoY Change	8.25%	5.35%	24.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.831B	-$1.728B	-$1.484B
YoY Change	19.14%	16.51%	24.6%
Common Stock	$1.028M	$1.018M	$893.0K
YoY Change	14.6%	14.0%	15.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$275.9M	$357.1M	$304.0M
YoY Change
Total Liabilities & Shareholders Equity	$796.2M	$840.7M	$763.1M
YoY Change	7.26%	10.17%	15.36%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$102.2M	-$63.66M	-$60.68M
YoY Change	92.89%	4.91%	-30.84%
Depreciation, Depletion And Amortization	$3.840M	$3.640M	$2.250M
YoY Change	8.47%	61.78%	136.84%
Cash From Operating Activities	-$66.79M	-$58.67M	-$52.37M
YoY Change	50.43%	12.03%	-19.26%
INVESTING ACTIVITIES
Capital Expenditures	-$1.510M	-$750.0K	-$14.59M
YoY Change	-88.42%	-94.86%	688.65%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.510M	-$750.0K	-$14.59M
YoY Change	-88.42%	-94.86%	688.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	12.01M	6.100M	1.360M
YoY Change	29.98%	348.53%	-6900.0%
NET CHANGE
Cash From Operating Activities	-66.79M	-58.67M	-52.37M
Cash From Investing Activities	-1.510M	-750.0K	-14.59M
Cash From Financing Activities	12.01M	6.100M	1.360M
Net Change In Cash	-56.29M	-53.32M	-65.60M
YoY Change	16.78%	-18.72%	-1.69%
FREE CASH FLOW
Cash From Operating Activities	-$66.79M	-$58.67M	-$52.37M
Capital Expenditures	-$1.510M	-$750.0K	-$14.59M
Free Cash Flow	-$65.28M	-$57.92M	-$37.78M
YoY Change	108.16%	53.31%	-40.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40375000	USD
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001104506
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-30739
	dei	Entity Registrant Name EntityRegistrantName	INSMED INC
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	54-1972729
	dei	Entity Address Address Line1 EntityAddressAddressLine1	700 US Highway 202/206
	dei	Entity Address City Or Town EntityAddressCityOrTown	Bridgewater
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08807
	dei	City Area Code CityAreaCode	908
	dei	Local Phone Number LocalPhoneNumber	977-9900
	dei	Security12b Title Security12bTitle	Common stock, par value $0.01 per share
	dei	Trading Symbol TradingSymbol	INSM
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	101867707	shares
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	588753000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	487429000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15196000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	19232000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	43483000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	28313000	USD
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19717000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20220000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	667149000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	555194000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	49937000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	53682000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	55314000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60180000	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	10603000	USD
CY2019Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	15256000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	32505000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	37673000	USD
CY2020Q3	us-gaap	Other Assets OtherAssets	25207000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	20314000	USD
CY2020Q3	us-gaap	Assets Assets	840715000	USD
CY2019Q4	us-gaap	Assets Assets	742299000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	22147000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13184000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35149000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	16283000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	19140000	USD
CY2020Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	582000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1221000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	9741000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11040000	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	280000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	83902000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	85240000	USD
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	351127000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	335940000	USD
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	15003000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	19529000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23198000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	29308000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10424000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10608000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	483654000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	480625000	USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101803701	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101803701	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	89682387	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	89682387	shares
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	1018000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	897000	USD
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2084305000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1797286000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1728376000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1536499000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	114000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	357061000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	261674000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	840715000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	742299000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	43643000	USD
CY2019Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	38885000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	122998000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	90759000	USD
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10622000	USD
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6437000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	29010000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	15506000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	33021000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	32448000	USD
	us-gaap	Gross Profit GrossProfit	93988000	USD
	us-gaap	Gross Profit GrossProfit	75253000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	41411000	USD
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34340000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	113343000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	99081000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46585000	USD
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	53347000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	147594000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	160590000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1248000	USD
CY2019Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1249000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3745000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3745000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	89244000	USD
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	88936000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	264682000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	263416000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-56223000	USD
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-56488000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-170694000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-188163000	USD
CY2020Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	70000	USD
CY2019Q3	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	2885000	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1677000	USD
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	7879000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	7185000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	6846000	USD
	us-gaap	Interest Expense InterestExpense	22065000	USD
	us-gaap	Interest Expense InterestExpense	20357000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4000	USD
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-85000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-14000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-255000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-63342000	USD
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-60534000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-191096000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-200896000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	317000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	148000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	781000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	453000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-63659000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-60682000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-191877000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-201349000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.63
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.68
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.43
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	101615000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	89245000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	96029000	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	82907000	shares
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-63659000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-60682000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-191877000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-201349000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	212000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	124000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-63447000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-60682000	USD
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1000	USD
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-60683000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-191753000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-201348000	USD
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	356573000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-104000	USD
CY2019Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6794000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	304041000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	405318000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-63659000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	212000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-47000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8909000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	357061000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	208266000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-201349000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	261074000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21083000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	304041000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	261674000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-191877000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	124000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	245865000	USD
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	27379000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	357061000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-191877000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-201349000	USD
	us-gaap	Depreciation Depreciation	6829000	USD
	us-gaap	Depreciation Depreciation	3249000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3745000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3745000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	27379000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	21083000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1048000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1047000	USD
	insm	Amortization Of Debt Discount Premium And Accretion Expense AmortizationOfDebtDiscountPremiumAndAccretionExpense	14139000	USD
	insm	Amortization Of Debt Discount Premium And Accretion Expense AmortizationOfDebtDiscountPremiumAndAccretionExpense	13398000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	809000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
	insm	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	5168000	USD
	insm	Noncash Operating Lease Expense NoncashOperatingLeaseExpense	6938000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-4036000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9831000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15116000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	15305000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-191900000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16281000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-631000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10156000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	4786000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9120000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1410000	USD
	insm	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	-10613000	USD
	insm	Increase Decrease In Accrued Liabilities And Other Current Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherCurrentLiabilities	4061000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3068000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-8254000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-152556000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-206245000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5307000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	29230000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5307000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-29230000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	588800000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	13896000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	14966000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	245865000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	261074000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	769000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	258992000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	276040000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	195000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	101324000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	40560000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	487429000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	495072000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	588753000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	535632000	USD
	us-gaap	Interest Paid Net InterestPaidNet	8847000	USD
	us-gaap	Interest Paid Net InterestPaidNet	7880000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	780000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	320000	USD
	insm	Fair Value Level1 Level2 Level3 Transfers Amount FairValueLevel1Level2Level3TransfersAmount	0	USD
	insm	Fair Value Level1 Level2 Level3 Transfers Amount FairValueLevel1Level2Level3TransfersAmount	0	USD
CY2020Q3	insm	Availableforsale Securities Gross Unrealized Gain Loss Numberof Securities AvailableforsaleSecuritiesGrossUnrealizedGainLossNumberofSecurities	0	security
CY2019Q4	insm	Availableforsale Securities Gross Unrealized Gain Loss Numberof Securities AvailableforsaleSecuritiesGrossUnrealizedGainLossNumberofSecurities	0	security
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-63659000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-60682000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-191877000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-201349000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	101615000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	89245000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96029000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	82907000	shares
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	101615000	shares
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89245000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96029000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	82907000	shares
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.63
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.68
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.00
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.43
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">—Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash equivalents with high credit-quality financial institutions and may invest its short-term investments in US treasury securities, mutual funds and government agency bonds. The Company has established guidelines relative to credit ratings and maturities that seek to maintain safety and liquidity.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to risks associated with extending credit to customers related to the sale of products. The Company does not require collateral to secure amounts due from its customers. The Company uses an expected loss methodology to calculate allowances for trade receivables. The Company's measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable </span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">forecasts that affect the collectability of the reported amount. The Company does not currently have a material allowance for collectible trade receivables. The following table presents the percentage of total gross product revenue represented by the Company's three largest customers as of the nine months ended September 30, 2020 and September 30, 2019.</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:67.836%"><tr><td style="width:1.0%"/><td style="width:37.908%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.994%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:27.997%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:42.75pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third-party manufacturers and suppliers for manufacturing and supply of its products. The inability of the suppliers or manufacturers to fulfill supply requirements of the Company could materially impact future operating results. A change in the relationship with the suppliers or manufacturers, or an adverse change in their business, could materially impact future operating results.</span></div>
CY2020Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14546000	USD
CY2020Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	18937000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16048000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6420000	USD
CY2020Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10000000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	5845000	USD
CY2020Q3	us-gaap	Inventory Net InventoryNet	43483000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	28313000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	49900000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	53700000	USD
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P12Y
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	5000000.0	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	5000000.0	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	5000000.0	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	5000000.0	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5000000.0	USD
	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	0	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	53682000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3745000	USD
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	49937000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	81346000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	79447000	USD
CY2020Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26032000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	19267000	USD
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	55314000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60180000	USD
CY2020Q3	insm	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	9984000	USD
CY2019Q4	insm	Accrued Clinical Trial Expenses AccruedClinicalTrialExpenses	5598000	USD
CY2020Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	9643000	USD
CY2019Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	12581000	USD
CY2020Q3	insm	Accrued Technical Operation Expenses AccruedTechnicalOperationExpenses	6153000	USD
CY2019Q4	insm	Accrued Technical Operation Expenses AccruedTechnicalOperationExpenses	6446000	USD
CY2020Q3	insm	Accrued Royalties And Milestone Payments Current AccruedRoyaltiesAndMilestonePaymentsCurrent	2094000	USD
CY2019Q4	insm	Accrued Royalties And Milestone Payments Current AccruedRoyaltiesAndMilestonePaymentsCurrent	3117000	USD
CY2020Q3	us-gaap	Interest Payable Current InterestPayableCurrent	1663000	USD
CY2019Q4	insm	Accrued Sales Allowancesand Related Costs AccruedSalesAllowancesandRelatedCosts	5267000	USD
CY2020Q3	insm	Accrued Construction Liabilities Current AccruedConstructionLiabilitiesCurrent	130000	USD
CY2019Q4	insm	Accrued Construction Liabilities Current AccruedConstructionLiabilitiesCurrent	2689000	USD
CY2019Q4	us-gaap	Interest Payable Current InterestPayableCurrent	3631000	USD
CY2020Q3	insm	Accrued Sales Allowancesand Related Costs AccruedSalesAllowancesandRelatedCosts	4993000	USD
CY2020Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	489000	USD
CY2019Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1046000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35149000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40375000	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	88000	USD
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	809000	USD
CY2020Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	91000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	962000	USD
CY2020Q3	insm	Finance Lease Cost FinanceLeaseCost	179000	USD
	insm	Finance Lease Cost FinanceLeaseCost	1771000	USD
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1393000	USD
	us-gaap	Operating Lease Cost OperatingLeaseCost	8279000	USD
CY2020Q3	us-gaap	Lease Cost LeaseCost	1572000	USD
	us-gaap	Lease Cost LeaseCost	10050000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020Q3	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	91000	USD
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	962000	USD
CY2020Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	1458000	USD
	us-gaap	Operating Lease Payments OperatingLeasePayments	8371000	USD
CY2020Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	179000	USD
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	769000	USD
CY2020Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P9Y9M18D
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y6M
CY2020Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.086
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.074
CY2020Q3	us-gaap	Variable Lease Cost VariableLeaseCost	6000000.0	USD
	us-gaap	Variable Lease Cost VariableLeaseCost	7100000	USD
CY2020Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2019Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	513000	USD
CY2019Q3	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	718000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	47389000	USD
	insm	Lessee Operating Lease Lease Notyet Commenced Amount LesseeOperatingLeaseLeaseNotyetCommencedAmount	23600000	USD
CY2020Q3	us-gaap	Secured Debt SecuredDebt	450000000	USD
CY2019Q4	us-gaap	Secured Debt SecuredDebt	450000000	USD
CY2020Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5995000	USD
CY2019Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	7043000	USD
CY2020Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	92878000	USD
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	107017000	USD
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	351127000	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	335940000	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2020Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	450000000	USD
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	450000000	USD
CY2020Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1968000	USD
CY2019Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1971000	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	7185000	USD
CY2019Q3	us-gaap	Interest Expense InterestExpense	6846000	USD
	us-gaap	Interest Expense InterestExpense	22065000	USD
	us-gaap	Interest Expense InterestExpense	20357000	USD
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	101803701	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	101803701	shares
CY2020Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	23.25
CY2020Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	13500000	USD
CY2019Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	26.00
CY2019Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	16000000.0	USD
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	insm	Share Based Compensation Arrangement By Share Based Payment Award Inducement Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardInducementOptionsGrantsInPeriodGross	890290	shares
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	300000	USD
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	500000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2019Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000	USD
CY2019Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	400000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2600000	USD
	us-gaap	Operating Lease Expense OperatingLeaseExpense	2000000.0	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	5916000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	5912000	USD
CY2020Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	350000	USD
CY2019Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	349000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1048000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1047000	USD
CY2020Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4776000	USD
CY2019Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4526000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	14139000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13398000	USD
CY2020Q3	insm	Convertible Debt Interest Expense Total ConvertibleDebtInterestExpenseTotal	7094000	USD
CY2019Q3	insm	Convertible Debt Interest Expense Total ConvertibleDebtInterestExpenseTotal	6846000	USD
	insm	Convertible Debt Interest Expense Total ConvertibleDebtInterestExpenseTotal	21103000	USD
	insm	Convertible Debt Interest Expense Total ConvertibleDebtInterestExpenseTotal	20357000	USD
CY2020Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	91000	USD
CY2019Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	0	USD
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	962000	USD

Files In Submission

Name	View Source	Status
0001104506-20-000019-index-headers.html	Edgar Link	pending
0001104506-20-000019-index.html	Edgar Link	pending
0001104506-20-000019.txt	Edgar Link	pending
0001104506-20-000019-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
insm-20200930.htm	Edgar Link	pending
insm-20200930.xsd	Edgar Link	pending
insm-20200930ex311.htm	Edgar Link	pending
insm-20200930ex312.htm	Edgar Link	pending
insm-20200930ex321.htm	Edgar Link	pending
insm-20200930ex322.htm	Edgar Link	pending
insm-20200930_cal.xml	Edgar Link	unprocessable
insm-20200930_def.xml	Edgar Link	unprocessable
insm-20200930_htm.xml	Edgar Link	completed
insm-20200930_lab.xml	Edgar Link	unprocessable
insm-20200930_pre.xml	Edgar Link	unprocessable
insm20200930ex101.htm	Edgar Link	pending
insm20200930ex1021.htm	Edgar Link	pending
insm20200930ex1022.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INSM
INSMED Inc Stock $insm

2020 Q4 Form 10-Q Financial Statement

#000110450620000019 Filed on October 29, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INSM INSMED Inc Stock $insm

2020 Q4 Form 10-Q Financial Statement

#000110450620000019 Filed on October 29, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INSM
INSMED Inc Stock $insm